Estrogen is reported to prevent age-associated epidermal thinning in the skin. We examined if 17b-estradiol (E2) may enhance the growth of human keratinocytes, focusing on its effects on the expression of cell cycle-regulatory proteins. E2 enhanced proliferation, bromodeoxyuridine incorporation of keratinocytes, and increased the proportion of cells in the S phase. The E2-induced stimulation of proliferation and bromodeoxyuridine incorporation was suppressed by antisense oligonucleotide against cyclin D2, which induces G 1 to S phase progression. E2 increased protein and mRNA levels of cyclin D2, and resultantly enhanced assembly and kinase activities of cyclin D2-cyclin-dependent kinases 4 or 6 complexes. E2 enhanced cyclin D2 promoter activity, and the element homologous to cAMP response element (CRE) on the promoter was responsible for the effect. Cyclin D2 expression was enhanced by antiestrogens, ICI 182,780 and 4-hydroxytamoxifen, and membrane-impermeable bovine serum albumin-conjugated E2, indicating the effects via membrane E2-binding sites. E2 increased the enhancer activity of CRE-like element and the amount of phosphorylated cAMP response element binding protein (CREB) binding this element, and the increases were suppressed by H-89, an inhibitor of cAMP-dependent protein kinase A. H-89 also suppressed E2-induced cyclin D2 expression, proliferation, and bromodeoxyuridine incorporation in keratinocytes. Antisense oligonucleotide against G-protein-coupled receptor GPR30 suppressed the E2-induced increases of phosphorylated CREB, cyclin D2 level, proliferation, and bromodeoxyuridine incorporation in keratinocytes. These results suggest that E2 may stimulate the growth of keratinocytes by inducing cyclin D2 expression via CREB phosphorylation by protein kinase A, dependent on cAMP. These effects of E2 may be mediated via cell surface GPR30.
Epidermal thinning in the skin proceeds with increasing age (Varani et al, 1998) . This may be caused by the ageassociated accumulation of replicative senescent keratinocytes arrested in the G 1 phase of the cell cycle (Dimri et al, 1995) . The transition from the G 1 to S phase is promoted by D-type cyclins (Campisi, 1998; Chung et al, 2000) . In the mid to late G 1 phase, D-type cyclins, cyclin D1, D2, or D3 associate with cyclin-dependent kinase 4 (Cdk4) or Cdk6, and induce these kinases to phosphorylate retinoblastoma tumor suppressor protein (pRb) (Gao and Zelenka, 1997) . Phosphorylation of pRb disrupts the inhibitory complexes preformed between pRb and E2F family transcription factors, permitting E2F-dependent transcription of genes required for DNA replication, such as thymidylate synthetase, thymidine kinase, or DNA polymerase a (Campisi, 1998) . On the other hand, p21 cip1 , p27 kip1 , or p16 INK4A bind and inactivate Cdks and thus suppress the cell cycle progression (Gao and Zelenka, 1997; Campisi, 1998) . Among three D-type cyclins, cyclin D2 mainly acts as a G 1 /S progressor in the skin (Chung et al, 2000) . It is reported that cyclin D2 expression is reduced in the aged skin (Chung et al, 2000) , whereas the expression of Cdk inhibitors is increased in senescent keratinocytes (Sayama et al, 1999; Chaturvedi et al, 1999) .
It has been reported that estrogen prevents or delays age-associated changes in the skin (Shah and Maibach, 2001) . Topical application of estrogen suppressed epidermal thinning in the aged skin (Goldzieher, 1946; Eller and Eller, 1949) and maintained skin thickness (Shah and Maibach, 2001; Sator et al, 2001) . Previous study reported that 17b-estradiol (E2) in vitro stimulated proliferation and DNA synthesis of human keratinocytes (Urano et al, 1995) , which may be related to the in vivo effects of E2 to prevent epidermal atrophy. But the precise mechanism for the growth-stimulatory effects of E2 is not identified, including the relation to the expression of cell cycle stimulators or inhibitors. It is known that E2 exerts its effects by two different mechanisms, genomic or non-genomic, and E2 may promote the growth of keratinocytes by either or both mechanisms. The genomic mechanism is that E2-bound nuclear estrogen receptor (ER) a or b simulates or inhibits gene expression by binding to estrogen response element of the target genes or by interacting with other transcription factors (Beato, 1989; Kanda and Watanabe, 2003a) . On the other hand, the non-genomic mechanism is that E2 interacts with cell surface binding sites and rapidly induces a variety of intracellular signals (Kelly and Levin, 2001) , such as activation of adenylate cyclase (AC) (Aronica et al, 1994) , phospholipase C (Razandi et al, 1999) , or extracellular signal-regulated kinase (ERK) (Migliaccio et al, 1996) . Membrane estrogen-binding sites do not appear to be a unique molecule; some may be post-translationally modified forms of nuclear ERa or b, and others may be structurally different from nuclear ERs (Papas et al, 1995; Razandi et al, 1999; Benten et al, 2001) . It is reported that estrogen can interact with several G-protein-coupled receptors like steroid hormone-binding globulin receptor (Fissore et al, 1994) , or an orphan receptor GPR30 (Filardo et al, 2002) .
In this study, we examined the in vitro effects of E2 on the proliferation and DNA synthesis of human keratinocytes. We found the stimulatory effects of E2. We further analyzed the mechanism for the effects of E2, focusing on the expression of cell cycle regulatory proteins.
Results
E2 stimulated the growth of keratinocytes E2 stimulated keratinocyte proliferation (Fig 1a) and BrdU incorporation ( Fig 1b) in parallel; the stimulatory effect of E2 was concentration-dependent, and was maximized at 10 À8 M, which increased the cell number 3.1-fold and BrdU incorporation 3.5-fold of controls, respectively. E2 stereoisomer 17a-estradiol did not stimulate proliferation or BrdU incorporation of keratinocytes. E2-BSA, membrane-impermeable bovine serum albumin-conjugated E2, increased the keratinocyte proliferation and BrdU incorporation with 10 À7 M of optimal concentration, indicating that the effect of E2 may be exerted via membrane E2-binding sites. Antiestrogens, ICI 182,780 and 4-hydroxytamoxifen stimulated the keratinocyte proliferation and BrdU incorporation with 10 À7 M of optimal concentration. The addition of these antiestrogens did not suppress the E2-induced increases in proliferation and BrdU incorporation (data not shown). Thus E2, E2-BSA, and antiestrogens stimulated the proliferation and BrdU incorporation in keratinocytes, and the effects appeared to occur at the membrane. These results indicate that E2 may induce G 1 /S transition of cell cycle since BrdU is incorporated into newly synthesized DNA of S phase cells. We then performed cell cycle analysis, and found that E2 increased the proportion of S phase cells and decreased that of G 0 /G 1 phase (Fig 2) , indicating the G 1 /S transition by E2. E2-BSA, 4-hydroxytamoxifen, and ICI 182,780 also increased the percentage of S phase and decreased that of the G 0 /G 1 phase (data not shown). Since D-type cyclins are required for G 1 /S transition whereas Cdk inhibitors suppress the actions of these cyclins, we then analyzed the effects of E2 on the expression of these cell cycle regulators.
E2 increased cyclin D2 protein and mRNA levels and induced assembly and activation of cyclin D2-Cdk4 or 6 complexes E2, E2-BSA, ICI 182,780, and 4-hydroxytamoxifen increased cyclin D2 mRNA (Fig 3a) and protein levels (Fig 3b) in keratinocytes, whereas these were not altered by 17a-estradiol or bovine serum albumin. The addition of ICI 182,780 or 4-hydroxytamoxifen did not suppress the effects of E2 on the cyclin D2 levels (data not shown). On the other hand, E2, E2-BSA, antiestrogens did not alter the mRNA (Fig 3a) and protein levels (data not shown) of cyclin D1, cyclin D3, or Cdk inhibitors p27 kip1 , p21 cip1 , or p16 INK4A . Thus E2, E2-BSA, and antiestrogens selectively increased cyclin D2 levels. The correlation of growth with cyclin D2 level indicates that the increase of cyclin D2 may be responsible for the growth-stimulation by E2. This is supported by the experiment using antisense oligonucleotides; antisense cyclin D2 suppressed constitutive and E2-induced growth of keratinocytes (Fig 4) .
Since cyclin D2 associates with Cdk4 or Cdk6 and enhances pRb phosphorylation by these Cdks (Fujita et al, 2002) ; we examined if E2 may increase the assembly of cyclin D2 with Cdk4 or 6. E2 increased the amounts of cyclin D2-Cdk4 or 6 complexes in keratinocytes, whereas did not increase those of cyclin D3-Cdk4 or 6 complexes (Fig 5a) . We next analyzed Cdk4 or 6-dependent kinase activities in keratinocytes. E2 enhanced the pRb-phosphorylating activities of immunoprecipitates with anti-cyclin D2, Cdk4, or Cdk6 antibodies, whereas it did not enhance that of anti-cyclin D3 immunoprecipitate (Fig 5b) . These results suggest that E2 may promote the assembly of cyclin D2-Cdk4 or 6 complexes and enhance Cdk4 or 6 kinase activities. E2-BSA, 4-hydroxytamoxifen, and ICI 182,780 also increased the assembly and kinase activities of cyclin D2-Cdk4 or 6 complexes (data not shown). We then examined if E2 may promote cyclin D2 promoter activity in keratinocytes.
E2 enhanced cyclin D2 promoter activity We transiently transfected full-length (À1624/À1 bp) or 5 0 -deleted (À444/ À1 bp) cyclin D2 promoters linked to luciferase reporter into keratinocytes, and the promoter activity was evaluated by relative luciferase activity of the cell lysates. E2 increased the activities of both full-length and 5 0 -deleted promoters to similar extents (Fig 6b, first and third two columns). E2-BSA, ICI 182,780, and 4-hydroxytamoxifen enhanced both promoter activities, whereas 17 a-estradiol did not increase either promoter activity (data not shown). The full-length cyclin D2 promoter contained E2F element and two NF-kBlike elements (NF-kB1, NF-kB2) (Fig 6a) . The mutation of these three elements did not decrease the basal or E2induced promoter activities (Fig 6b, second two columns), 
Figure 3
The effects of E2, E2-BSA, or antiestrogens on cyclin D2 mRNA (a) and protein levels (b). Keratinocytes were incubated with KBM alone or with 10 À8 M E2, 10 À7 M E2-BSA, 10 À7 M ICI 182,780 (ICI), 10 À7 M 4hydroxytamoxifen (4OHT), 10 À7 M bovine serum albumin (BSA), or 10 À8 M 17a-estradiol (17a-E2). After 3 h, total cellular RNAs or proteins were isolated. The intensity of the band for cyclin D2 was corrected to that for GAPDH, and the corrected intensities relative to that in control cells (set as 1.0) are shown. The results shown in the figures are representative of five separate experiments.
indicating that these elements may be dispensable for basal and E2-induced cyclin D2 promoter activities. 5 0 -deletion of cyclin D2 promoter at À444 bp lost these three upstream elements, however, retained downstream element (TTGCGTCA) related to consensus CRE (TGACGTCA) and two NF-kB-like elements (NF-kB3, NF-kB4) (Fig 6a) . The mutation of NF-kB3 or NF-kB4 (Fig 6b, four columns at the bottom) reduced the basal promoter activity by about 30%, respectively, however, did not reduce the magnitude of response to E2, indicating that these two elements may partially confer the basal promoter activity, however, may be dispensable for the E2-induced stimulation. In contrast, the mutation of CRE-like element (Fig 6b, fourth two columns) reduced the basal promoter activity by about 60% and completely abolished E2-induced stimulation. These results suggest that CRE-like element may confer the basal promoter activity and may be responsible for the activation by E2. Similar results on mutated promoters were obtained using E2-BSA or antiestrogens in place of E2 (data not shown). We then analyzed if E2 may promote enhancer activity of the CRE-like element.
E2 increased the enhancer activity of CRE-like element Keratinocytes were transiently transfected with luciferase reporter linked to four repeats of the CRE-like element in front of TATA box. E2 increased the enhancer activity of CRE-like element (Fig 7) . E2-BSA, ICI 182,780 and 4-hydroxytamoxifen increased the enhancer activity of the CRE-like element, whereas 17a-estradiol did not. It is known that the phosphorylation of transcription factor CREB at Ser 133 promotes its transcriptional activity at CRE (Kwok et al, 1994) . The phosphorylation of CREB recruits transcriptional coactivator CREB binding protein (CBP), which increases the interaction of CBP with basal transcription factor TFIIB, and thus facilitates CREBmediated transcription. We then performed EMSA and examined if E2 may enhance the phosphorylation of CREB binding the CRE-like element.
Figure 4
Inhibition by cyclin D2 antisense oligonucleotide on E2-induced stimulation of BrdU incorporation (a) and proliferation (b). Keratinocytes were pretreated with 0.2 mM of indicated antisense oligonucleotides (ASO) against cyclin D2 (CycD2) or control scrambled oligonucleotides (Con) for 4 h. The cells were then incubated with 10 À8 M E2. BrdU incorporation was analyzed at 24 h (a), and cell number was counted after 4 d (b). Values are mean AE SEM of five separate experiments. Ã po0.05 versus values with medium alone, wpo0.05 versus values with E2 alone, by one-way ANOVA with Scheffe's multiple comparison test.
Figure 6
Effects of E2 on wild type or mutated cyclin D2 promoters. (a) Schematic representation of human cyclin D2 promoter. Possible elements for E2F, CRE, and NF-kB are shown. The nucleotide positions are relative to the translational start site. (b) Keratinocytes were transiently transfected with wild type (WT) or mutated pCycD2-Luc together with pCH110, and incubated with medium alone or with 10 À8 M E2 for 5 h. Relative luciferase activities normalized to b-galactosidase activities are shown. The data are mean AE SEM (n ¼ 4). Values at right indicate the fold induction versus basal promoter activity. Ã po0.05 versus controls, by paired t test. E2 enhanced the phosphorylation of CREB binding the CRE-like element, dependent on cAMP/protein kinase A (PKA) pathway DNA-protein complex was obtained by the incubation of keratinocyte nuclear extracts with the cyclin D2 promoter-derived probe containing the CRE-like element (Fig 8a, lanes 2 and 3) . Anti-CREB antibody supershifted the complex (lanes 4 and 5), indicating the presence of CREB in the complex. E2 did not increase the amount of total CREB in the complex (lanes 4 and 5), however, increased the amount of Ser 133 -phosphorylated CREB in the complex (lanes 6 and 8). E2-BSA, ICI 182,780, and 4-hydroxytamoxifen also increased the amount of phosphorylated CREB without altering that of total CREB (data not shown). These results indicate that CREB may constitutively bind the CRE-like element, and that E2, E2-BSA, and antiestrogens may enhance the phosphorylation of the bound CREB, which may promote the transcription through this element. CREB is phosphorylated at Ser 133 by a variety of serine/threonine kinases, dependent on the stimuli or cell types, cAMP-dependent PKA, protein kinase C, Akt, Ca 2 þ /calmodulin-dependent protein kinase type IV, mitogen-activated protein kinase (MAPK)-activated protein kinase-2, p70 S6K or p90 rsk (Tan et al, 1996) . We then analyzed which of the kinases may be responsible for E2-induced CREB phosphorylation, using specific kinase inhibitors. H-89, an inhibitor of PKA, reduced the amounts of phosphorylated CREB both in the presence and absence of E2 (lanes 7 and 9), indicating the involvement of cAMP/ PKA signaling pathway for constitutive and E2-induced CREB phosphorylation. This is supported by the fact that cAMP analog dibutyryl cAMP increased the amount of phosphorylated CREB (lane 12). In parallel with the inhibition of CREB phosphorylation, H-89 suppressed constitutive and E2-induced enhancer activity of the CRE-like element, whereas dibutyryl cAMP increased the enhancer activity (Fig 8b) . These results suggest that cAMP/PKA pathway may be required for basal and E2-induced enhancer activity of the CRE-like element via phosphorylation of CREB. In contrast, the E2-induced increases in phosphorylated CREB and enhancer activity of the CRE-like element were not suppressed by calphostin C, LY294002 (Fig 8) , rapamycin, W-7, PD98059, or SB202190 (data not shown), which inhibit protein kinase C, phosphatidylinositol-3-OH kinase (PI-3K)/Akt signaling pathway, p70 S6K , Ca 2 þ / calmodulin-dependent protein kinase type IV, ERK kinase 1/ ERK/p90 rsk pathway, or p38 MAPK/MAPK-activated protein kinase-2 pathway, respectively. These indicate that the E2induced CREB phosphorylation may not involve protein kinase C, Akt, Ca 2 þ /calmodulin-dependent protein kinase type IV, MAPK-activated protein kinase-2, p70 S6K , or p90 rsk . These inhibitors did not suppress the basal enhancer activity of the CRE-like element (Fig 8b) or constitutive CREB phosphorylation (data not shown).
Figure 7
Effects of E2, E2-BSA, or antiestrogens on enhancer activity of CRE-like element. Keratinocytes were transiently transfected with p4xCRE-TATA-Luc or enhancerless pTATA-Luc together with pCH110. The cells were incubated with medium alone or with 10 À8 M E2, 10 À7 M E2-BSA, 10 À7 M ICI 182,780 (ICI), 10 À7 M 4-hydroxytamoxifen (4OHT), 10 À7 M bovine serum albumin (BSA), or 10 À8 M 17a-estradiol (17a-E2) for 5 h. The results are shown as relative luciferase activities normalized to b-galactosidase activities, and represent mean AE SEM (n ¼ 4). Values at right indicate the fold induction versus basal promoter activity. Ã po0.05 versus values with medium alone, by one-way ANOVA with Scheffe's multiple comparison test.
Figure 8
Effects of E2 or signal modulators on DNA binding of total or phosphorylated CREB (a) and enhancer activity of CRE-like element (b). (a) Keratinocytes were preincubated with 1 mM H-89, 1 mM calphostin C (CalC), or 10 mM LY294002 (LY) for 10 min, then incubated with KBM alone or with 10 À8 M E2 or 1 mM dibutyryl cAMP (Bt2cAMP). After 1 h, nuclear extracts were prepared. The nuclear extracts were incubated with 32 P-labeled oligonucleotides containing CRE-like element from cyclin D2 promoter. In supershift assays, antibodies against total CREB (C) or phosphorylated CREB (P) were incubated for 30 min before the addition of the probe. Arrows indicate the DNA-protein complexes and supershifted complexes. The results shown in the figure are representative of five separate experiments. (b) Keratinocytes were transiently transfected with p4xCRE-TATA-Luc together with pCH110. The cells were preincubated with signal inhibitors, then incubated with E2 or Bt2cAMP as described above for 5 h. The results are shown as relative luciferase activities normalized to b-galactosidase activities, and represent mean AE SEM (n ¼ 4). Ã po0.05 versus values with medium alone, and wpo0.05 versus values with E2 alone, by one-way ANOVA with Scheffe's multiple comparison test.
E2-induced cyclin D2 expression and growth-stimulation were dependent on cAMP/PKA pathway We then analyzed if E2-induced cyclin D2 expression and growthstimulation may be suppressed by PKA inhibitor. H-89 suppressed both constitutive and E2-induced cyclin D2 promoter activity (Fig 9a) , cyclin D2 protein expression ( Fig  9d) , BrdU incorporation (Fig 9b) , and proliferation (Fig 9c) . In parallel with the inhibition of cyclin D2 expression, H-89 inhibited constitutive and E2-induced assembly of cyclin D2 with Cdk4 (Fig 9e) or Cdk6 (data not shown) and pRbphosphorylating activities of immunoprecipitates with anticyclin D2, Cdk4 (Fig 9f) , or Cdk6 antibodies (data not shown). H-89 also inhibited the cyclin D2 expression and growth-stimulation induced by E2-BSA, ICI 182,780, or 4hydroxytamoxifen (data not shown). On the other hand, dibutyryl cAMP enhanced cyclin D2 expression, assembly and kinase activities of cyclin D2-Cdk4 complex, and growth in keratinocytes (Fig 9) . These results indicate that cAMP/PKA signaling pathway may be required for basal and E2-induced cyclin D2 expression and activity to promote DNA synthesis and proliferation.
Antisense GPR30 suppressed E2-induced CREB phosphorylation and cyclin D2 expression Since membraneimpermeable E2-BSA induced cyclin D2 expression dependent on PKA, E2 may act on the cell surface of keratinocytes and may activate cAMP/PKA pathway. We also recently found that E2, E2-BSA, and antiestrogens increased intracellular cAMP level in human keratinocytes by activating AC (Kanda and Watanabe, 2003b) . The induced cAMP may bind to PKA regulatory subunits, which may release and activate PKA catalytic subunits precomplexed with the regulatory subunits. It is reported that E2-induced cAMP signal is mediated via membranelocalized ERa, ERb (Razandi et al, 1999) , or GPR30 (Filardo et al, 2002) . We have detected ERb and GPR30 mRNAs, but not that of ERa in keratinocytes by RT-PCR Watanabe, 2003b, 2003d) . This indicates that ERa or GPR30 localized at the membrane may mediate the E2-induced cAMP signal and CREB phosphorylation in keratinocytes. Since specific antibody against GPR30 cannot be obtained, we analyzed if ERb or GPR30 antisense oligonucleotides may inhibit E2-induced CREB phosphorylation. GPR30 antisense did but ERb antisense did not suppress the E2-induced increases in phosphorylated CREB (Fig 10a) , cyclin D2 level (Fig 10b) , BrdU incorporation (Fig 10c) , and proliferation (Fig 10d) . E2-BSA, ICI 182,780, or 4-hydroxytamoxifen-induced CREB phosphorylation, cyclin D2 expression, and growth-stimulation were also suppressed by GPR30 antisense but not by ERb antisense (data not shown). These results suggest that cell surface GPR30 may mediate the E2, E2-BSA, and antiestrogen-induced CREB phosphorylation, cyclin D2 expression, and growth-stimulation, whereas ERb may not be involved in these effects.
Discussion
In this study, E2 enhanced the growth of keratinocytes by inducing cyclin D2 expression. The induced cyclin D2 associated with Cdk4 or 6 and enhanced their pRbphosphorylating activity. The pRb phosphorylation may release and activate E2F prebound by pRb, and promote the E2F-dependent transcription of genes required for DNA replication (Gao and Zelenka, 1997) . The E2-induced cyclin D2 transcription was mediated via CREB phosphorylation by cAMP-dependent PKA. Previous study also reported that E2 induced cAMP signal, CREB phosphorylation, and CREB-dependent neurotensin gene expression in neuronal SK-N-SH cells (Watters and Dorsa, 1998) . It is reported that cAMP-elevating agents promote cyclin D2 expression and enhance the growth of rat or mouse ovarian granulosa cells (Sicinski et al, 1996; Robker and Richards, 1998) . In these studies, however, the precise mechanism for cAMPinduced cyclin D2 expression is not shown. This study elucidated that CRE-like element (À294/À287 bp) on cyclin D2 promoter may act as a cAMP-inducible element. This element also acted as an enhancer element for cyclin D2 transcription induced by HTLV-I oncogene product Tax in human T cells (Huang et al, 2001) . In Tax-induced transcription, however, the cooperation with NF-kB3 (À131/À 121 bp) was required for the CRE-like element to be functional. On the other hand, the CRE-like element appeared to act independently of NF-kB3 in E2-stimulated keratinocytes (Fig 6) . This difference indicates that cyclin D2 expression is distinctly regulated dependent on the stimuli or cell types.
E2 appeared to induce cAMP/PKA pathway in keratinocytes via membrane G-protein-coupled receptor, GPR30.
Figure 9
Inhibition by PKA inhibitor on E2-induced increases in cyclin D2 promoter activity (a), BrdU incorporation (b), proliferation (c), cyclin D2 protein level (d), assembly (e), and kinase activities (f) of cyclin D2-Cdk4 complex. (a) Keratinocytes were transiently transfected with pCycD2-Luc together with pCH110, and preincubated with 1 mM H-89 for 10 min, then incubated with KBM alone, or 10 À8 M E2 or 1 mM dibutyryl cAMP (Bt2cAMP) for another 5 h. Luciferase activities of the cell lysates were analyzed and were normalized to b-galactosidase activities. (b-f) Keratinocytes without transfection were incubated as above. BrdU incorporation was analyzed after 24 h (b), cell number was counted after 4 d (c), and cell extracts were obtained after 3 h (d-f). The cell extracts were immunoblotted with anti-cyclin D2 antibody (d), or immunoprecipitated with anti-Cdk4 antibody, then immunoblotted with anti-cyclin D2 antibody (e). In vitro kinase assay was performed on immunoprecipitates with antibodies against cyclin D2 or Cdk4 using GST-pRb as a substrate (f Previous study also reported that E2 generated cAMP signal via GPR30 in breast cancer cells (Filardo et al, 2002) and macrophages (Kanda and Watanabe, 2003c) . In these studies, tamoxifen derivatives or ICI compounds induced cAMP signal, whereas 17a-estradiol did not. These are consistent with our present results, and indicate that tamoxifen derivatives or ICI compounds may act as agonists for GPR30, whereas 17a-estradiol may not. Besides E2 generated cAMP signal independently of ERb in the previous (Filardo et al, 2002; Kanda and Watanabe, 2003c) and in these studies (Fig 10) . Since activation of GPR30 induced cAMP signal, GPR30 may possibly be linked to AC via G s . It is hypothesized that the binding of E2 may activate GPR30 and induce the dissociation of the receptor-coupled G-protein heterotrimers, possibly G s abg, into G s a and Gbg, the former of which may stimulate AC. A ligand for GPR30 has not been identified yet, however, may be a certain peptide or glycoprotein (Carmeci et al, 1997) . GPR30 mRNA is ubiquitously expressed in the brain, lung, liver, prostate, or colon (Owman et al, 1996) . Thus GPR30mediated cyclin D2 expression and growth-stimulation may generally occur in a variety of tissues, and this possibility should further be examined.
CREB can be phosphorylated at Ser 133 by serine/ threonine kinases different from PKA (Tan et al, 1996) . E2 induced CREB phosphorylation by activating PI-3K/Akt pathway in rat cortical neurons (Honda et al, 2001) . But the activation of PI-3K/Akt pathway by E2 is rather unlikely in keratinocytes lacking ERa, since PI-3K is activated by E2bound ERa but not by ERb (Simoncini et al, 2000) . In the cell types other than keratinocytes, E2 induced intracellular Ca 2 þ signal (Benten et al, 2001) , activated phospholipase C/protein kinase C pathway (Le Mellay et al, 1999) or src/ Ras/ERK kinase/ERK pathway (Migliaccio et al, 1996) , all of which are relevant to CREB phosphorylation. But in keratinocytes, these E2-induced signals may not occur, or may be insufficient, if any, for CREB-mediated cyclin D2 transcription, possibly because the magnitude of the signals may be small and/or their duration may be short.
Previous studies reported that cAMP regulated the growth of keratinocytes dependent on its concentration; low level (10 À6 or 10 À5 M) of dibutyryl cAMP stimulates, whereas high level (10 À3 M) inhibits DNA replication or proliferation (Falanga et al, 1991; Onuma et al, 2001) . The growth-inhibition by high level of cAMP may be related to the induction of p27 Kip1 , which inactivates cyclin D-Cdk4 complexes. In murine macrophages, 10 À3 M of dibutyryl cAMP increased the level of p27 Kip1 , which counteracted the pRb-phosphorylating activity of cyclin D-Cdk4 complexes and induced G 1 phase arrest (Kato et al, 1994) . They suggested that the cell growth may be regulated by the relative expression of D-type cyclins and p27 Kip1 . Robker and Richards (1998) also suggested that low level of cAMP, e.g., FSH stimulus, may enhance the proliferation of granulosa cells by increasing cyclin D2 level without inducing p27 Kip1 , whereas high level of cAMP, e.g., LH surge, may increase the level of p27 Kip1 , exceeding the effect of cyclin D2, and may totally inhibit the proliferation. It is thus hypothesized that the threshold of cAMP for p27 Kip1 induction may be higher than that for cyclin D2. In human keratinocytes, E2 did not increase p27 Kip1 mRNA (Fig 3) or protein levels (data not shown) at various concentrations ranging from 10 À12 to 10 À6 M. In our previous study, E2 increased intracellular cAMP concentration maximally 4-5 fold of the basal level in human keratinocytes (Kanda and Figure 10 Inhibition by GPR30 antisense oligonucleotide on E2-induced increases in phosphorylated CREB (a), cyclin D2 protein level (b), BrdU incorporation (c), and proliferation (d). Keratinocytes were pretreated with 0.2 mM of indicated antisense oligonucleotides (ASO) or control scrambled oligonucleotides (Con) for 4 h. The cells were then incubated with 10 À8 M E2. EMSA was performed at 1 h (a) using antibody against phosphorylated CREB (P). Cyclin D2 protein level was evaluated at 3 h (b), BrdU incorporation was analyzed at 24 h (c), and cell number was counted after 4 d (d). The results shown in (a, b) are representative of five separate experiments. In (c, d) , values are mean AE SEM of five separate experiments. Ã po0.05 versus values with medium alone, wpo0.05 versus values with E2 alone, by one-way ANOVA with Scheffe's multiple comparison test. Watanabe, 2003b) , which may be insufficient for the induction of p27 Kip1 .
In this study, E2 directly stimulated the growth of keratinocytes via cyclin D2. To date, fibroblasts have been thought as a main target of E2 in the skin; E2 induces fibroblasts to synthesize extracellular matrix by promoting TGF-b1 production, which was considered as the main mechanism for the increase of skin thickness by E2 (Shah and Maibach, 2001) . Our present results, however, suggest that another possible mechanism is the direct growthstimulation on keratinocytes. E2 may thus prevent or delay age-associated epidermal atrophy by inducing cyclin D2 expression in keratinocytes. Our results also suggest that E2 may promote re-epithelialization in the wound. It is reported that E2 accelerates cutaneous wound healing (Ashcroft et al, 1997) . We also recently found that E2 induced human macrophages to produce nerve growth factor, a cytokine that enhances proliferation of keratinocytes (Kanda and Watanabe, in press (b) ). Taken together, E2 may promote re-epithelialization in the wound via both direct growth-stimulation on keratinocytes and indirect mechanism through accessory cells. Re-epithelialization in the wound is delayed in aged skin (Xia et al, 2001) , which may be partially due to the age-associated reduction of growth potential in keratinocytes (Gilchrest and Taar, 1992; Varani et al, 1998) . Topical application of E2 may thus be therapeutically useful for the delayed wound healing in the aged skin.
Materials and Methods
Reagents E2, 17b-estradiol 6-(O-carboxymethyl)oxime:bovine serum albumin (E2-BSA), 17a-estradiol, and 4-hydroxytamoxifen were purchased from Sigma (St Louis, Missouri). ICI 182,780 was from Wako Pure Chemical Industries (Osaka, Japan). LY294002, calphostin C, rapamycin, W-7, PD98059, SB202190, and N-[2-((p-bromociannamyl) amino)ethyl]-5-isoquinolinesulfonamide (H-89) were obtained from Calbiochem (La Jolla, California). Monoclonal antibodies against cAMP response element (CRE) binding protein (CREB) and Ser 133 -phosphorylated CREB were purchased from New England Biolabs (Beverly, Massachusetts). Antibodies against human cyclin D1, cyclin D2, cyclin D3, Cdk4, and Cdk6 were from Santa Cruz Biotechnology (Santa Cruz, California). Antiglyceraldehyde-3-phosphate dehydrogenase (GAPDH) monoclonal antibody was from American Research Products (Belmont, Massachusetts).
Culture of keratinocytes Normal human keratinocytes from sunprotected, disease-free chest skin of a 70-y-old Caucasian woman (Clonetics, Walkersville, Maryland) were cultured in serum-free KGM medium (Clonetics) consisting of basal medium MCDB153 supplemented with 0.5 mg mL hydrocortisone, 5 ng per mL epidermal growth factor, 5 mg per mL insulin, and 0.5% bovine pituitary extract. The cells in the third passage were used.
Measurement of bromodeoxyuridine (BrdU) incorporation and proliferation of keratinocytes BrdU incorporation was measured by ELISA using the BrdU Labeling and Detection Kit (Roche, Indianapolis, Indiana) according to the manufacturer's instruction. Keratinocytes (5 Â 10 3 per well) were seeded in triplicate into 96well plates in 100 mL KGM, adhered for 8 h, then the medium was changed to phenol red-free, basal KBM depleted of growth supplements, and incubated for 18 h. The medium was removed and the cells were incubated with indicated hormones in phenol red-free KBM for 20 h. The cells were then incubated with 10 mM BrdU for another 4 h. Cells were subjected to immunostaining with anti-BrdU monoclonal antibody. BrdU incorporation was evaluated by the absorbance at 405 nm minus that at 492 nm. In parallel experiments, keratinocytes were seeded at 1 Â 10 4 cells per well into 24-well plates, adhered for 8 h, starved for 18 h, then re-fed with fresh phenol red-free KBM including hormones. After 4 d, the cells were harvested, and total cell number was counted using a hemocytometer.
Cell cycle analysis Keratinocytes were incubated with hormones for 24 h as above, then harvested and suspended in 0.1% sodium citrate and 0.1% Triton-X-100 containing 50 mg per mL propidium iodide and 1 mg per mL RNase (Calbiochem) for 30 min. DNA fluorescence was measured with a FACScan flow cytometer (Becton Dickinson, San Diego, California), and the percentages of cells within G 0 /G 1 , S, and G 2 /M phases of the cell cycle were determined as described (van Ruissen et al, 1994) .
RT-PCR Keratinocytes were incubated as above, then the total cellular RNA was extracted using TRIzol reagent (Invitrogen, Rockville, Maryland). We reverse transcribed 0.5 mg of total RNA to produce cDNA as described (Tjandrawinata et al, 1997) , and 1/ 30 of synthesized cDNA was thermocycled for PCR amplification with 1 mM each primer and 1.5 U of Taq polymerase (Invitrogen). Primers for amplification and the sizes of respective PCR products were as follows: cyclin D1, 5 0 -AGGAGAACAAACAGATCA-3 0 and 5 0 -TAGGACAGGAAGTTGTTG-3 0 for 162 bp; cyclin D2, TCAT-GACTTCATTGAGCA-3 0 and 5 0 -CACTTCCTCATCCTGCTG-3 0 for 195 bp; cyclin D3, 5 0 -ACATGATTTCCTGGCCTT-3 0 and 5 0 -TGAGCTCATCCCCGGACA-3 0 for 220 bp; p16 INK4A , 5 0 -AGCAG-CATGGAGCCTTCGGC-3 0 and 5 0 -CTCTCTGGTTCTTTCAATCG-3 0 for 475 bp; p21 Cip1 , 5 0 -ACAGCAGAGGAAGACCATGT-3 0 and 5 0 -GGTATGTACATGAGGAGGTG-3 0 for 319 bp; p27 Kip1 , TGCAGAGA-CATGGAAGAGGC-3 0 and CGTTTGACGTCTTCTGAGGC-3 0 for 449 bp; GAPDH, 5 0 -GCAGGGGGGAGCCAAAAGGG-3 0 and 5 0 -TGCCAGCCCCAGCGTCAAAG-3 0 for 566 bp (Scwaller et al, 1997; Yu et al, 2002; Kanda and Watanabe, 2003a) . PCR was performed by one denaturing cycle of 951C for 3 min, 25 cycles of denaturation at 951C for 30 s, annealing at 581C for 30 s, and extension at 721C for 30 s, and a final extension at 721C for 3 min.
In preliminary experiments, 25 cycles lay in the exponential phase of amplification for each gene examined. The PCR products were analyzed by electrophoresis on 2.5% agarose gels and stained with ethidium bromide, viewed by UV light. Densitometric analysis of the bands was performed by NIH Image Software (http:// rsb.info.nih.gov/nih-image/). The mRNA levels of D-type cyclins or Cdk inhibitors were normalized for that of GAPDH.
Western blot analysis Keratinocytes incubated under the indicated conditions were lysed and centrifuged as described (Kanda and Watanabe, 2002) . Protein concentration in the supernatant was determined by BioRad DC reagent (Bio-Rad Laboratories, Hercules, California). For western analysis, 20 mg of proteins were resolved on a 10% SDS-polyacrylamide gel. The proteins were transferred onto a PVDF membrane. The membrane was blocked, and exposed to primary antibodies, followed by peroxidaseconjugated secondary antibodies (Bio-Rad). The blots were developed with an enhanced chemiluminescence kit (Amersham, Arlington Heights, Illinois). Densitometric analysis of the bands was performed by NIH Image Software.
Kinase assays In vitro kinase assay was performed in immunoprecipitates with antibodies against cyclin D2, cyclin D3, Cdk4, or Cdk6. Keratinocytes were lysed in lysis buffer (50 mM Hepes, 150 mM NaCl, 10% glycerol, 1% Triton-X, 1.5 mM MgCl 2 , 1 mM EGTA, 100 mM NaF, 500 mM Na 3 VO 4 , 10 mg per mL aprotinin, 10 mg per mL leupeptin, and 1 mM PMSF). Two hundred micrograms of the lysates were immunoprecipitated with various antibodies using Sepharose G beads (Pharmacia, Uppsala, Sweden), washed four times with lysis buffer, then washed twice with kinase buffer (80 mM sodium b-glycerophosphate, pH 7.4, 20 mM EGTA, 15 mM Mg(OAc) 2 , and 1 mM dithiothreitol), and then mixed with 10 mL kinase buffer containing 50 mM ATP, 1.25 mCi[a-32 P]ATP, and 1 mg glutathione S-transferase-retinoblastoma protein (GST-pRb). The samples were incubated at 301C for 30 min and the reactions were terminated by addition of 30 mL Laemli sample buffer. The samples were separated on 10% SDS-polyacrylamide gel and visualized by autoradiography. In parallel experiments, the immunoprecipitates with anti-Cdk4 or Cdk6 antibodies were immunoblotted with anticyclin D2 or cyclin D3 antibodies, and developed.
Plasmids and transfections
The firefly luciferase reporter plasmid driven by human cyclin D2 promoter (À1624/À1 bp relative to the translational start site) was constructed by PCR and insertion into pGL3 basic vector (Promega, Madison, Wisconsin) as described (Ohtani et al, 2000) , and was denoted as pCycD2-Luc. Site-specific mutation of the promoter was created by multiple rounds of PCR using primers with altered bases as described (Huang et al, 2001) . The sequences of these mutants are; E2F site: GCGCGAAA to GCATGAAA, NF-kB-like element 1: GAAGAGCC-CCC to GAAGAGGTTCC, NF-kB-like element 2: CGGGGCTTTCG to CGAACCTTTCG, CRE-like element: TTGCGTCA to TTGCGCAG, NF-kB-like element 3: CGAAAACCCCC to CGAAAAATTCC, and NF-kB-like element 4: AGAAAAACCCT to AGAACAGTTCT. p4xCRE-TATA-Luc was constructed by inserting four copies of CRE-like element (5 0 -CCAGCTTGCGTCACCGCT-3 0 ) from cyclin D2 promoter in front of TATA box upstream of firefly luciferase reporter as described (Kanda and Watanabe, 2003a) . Transient transfections were performed with Effectene (Qiagen, Tokyo, Japan) as described (Zellmer et al, 2001) . The efficiency of transfection into keratinocytes by this method was mean AE SEM 28.5 AE 3.1% (n ¼ 9) as determined by flow cytometry using bgalactosidase vector. Keratinocytes were plated in 10-cm dishes and grown to about 60% confluence. Twenty-four hours before the transfection, the medium was changed to phenol red-free KBM. Keratinocytes were incubated for 6 h with 5 mg of pCycD2-Luc or p4xCRE-TATA-Luc and 1 mg of SV40 promoter-linked b-galactosidase reporter vector, pCH110 (Amersham), premixed with enhancer, transfection buffer, and Effectene. The transfected cells were washed and incubated in fresh phenol red-free KBM for 18 h, then incubated with indicated hormones. After 5 h, cell extracts were prepared and luciferase activities were quantified using luciferase assay system (Promega). The same cell extracts were assayed for b-galactosidase activity using chemiluminescent Galacto-Light kit (Tropix, Bedford, Massachusetts). All readings were taken using a Lumat 9501 luminometer (Berthold, Wildbach, Germany). The results obtained in each transfection were normalized for b-galactosidase activity and expressed as relative luciferase activity. In our preliminary experiments, E2 did not alter the control b-galactosidase activity (data not shown).
Electrophoretic mobility shift assay (EMSA) EMSA was performed as described (Huang et al, 2001) . The probe used was 32 Plabelled annealed double-stranded DNA containing CRE-like element from human cyclin D2 promoter: CCAGCCAGCTTGCGT-CACCGCTTCAGA. For EMSA, 2-5 mg of nuclear protein extracts were incubated at room temperature for 5 min with a mixture containing 6 mM Hepes (pH 7.9), 0.4 mM EDTA, 125 mM KCl, 10% glycerol, 0.05 mg per mL poly dI-dC, 1 mM DTT, 2.5 mM sodium pyrophosphate, 1 mM b-glycerophosphate, 1 mM Na 3 VO 4 , 10 mM NaF, 50 mg per mL aprotinin, 50 mg per mL leupeptin. One nanogram of labeled probe was added and the reactions were incubated for another 20 min. In antibody supershift experiments, the nuclear extracts were pre-incubated with antibodies against CREB or Ser 133 -phosphorylated CREB for 30 min before the addition of probe. Reactions were then fractionated on a nondenaturing 5% polyacrylamide gel, and visualized with phosphorimager (Molecular Dynamics, Sunnyvale, California).
Treatment with antisense oligodeoxynucleotides Antisense oligonucleotides were synthesized as described (Lau et al, 2000; O'Dowd et al, 1998; Wu et al, 1995) . The oligonucleotides were ERb, 5 0 -CATCACAGCAGGGCTATA-3 0 ; GPR30, 5 0 -TTGGGAAGT-CACATCCAT-3 0 ; cyclin D2, 5 0 -ACAGCAGCTCCATGGCCAG-3 0 ; random control, 5 0 -GATCTCAGCACGGCAAAT-3 0 . For antisense experiments, keratinocytes were washed twice in phosphatebuffered saline, then transfected finally with 0.2 mM of the indicated oligonucleotides premixed with Superfect Reagent (Qiagen) in phenol red-free KBM for 4 h. The medium was aspirated and fresh medium containing E2 was added.
